IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Read more about IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF US Application 17/214,436Filed on 2021-03-26
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Read more about IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Japan2021-517344Filed on 2019-09-30
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY Read more about COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY Japan2021-515623Filed on 2019-09-20
TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications Read more about TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications United Kingdom14779019.0Filed on 2014-03-12
TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications Read more about TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications France14779019.0Filed on 2014-03-12
TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications Read more about TetraHydroxomate Chelators of Zirconium89 and Niobium90 for use in Diagnostic Applications Germany14779019.0Filed on 2014-03-12
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Portugal18188913.0Filed on 2018-08-14
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer The Netherlands18188913.0Filed on 2018-08-14
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Italy18188913.0Filed on 2018-08-14
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Ireland18188913.0Filed on 2018-08-14